Striae Alba is among one of the top body-related concerns of patients today. New advances in NanoFractional and radio frequency technology have made some significant strides in Striae Alba treatments.
As a medical aesthetics practitioner you know stretch marks are frustratingly difficult to treat. But recent academic research is pointing to a promising treatment. A study published in the Journal of Cosmetic Dermatology evaluated Venus Viva™ for treatment of striae alba, the chronic form of stretch marks.
The results were statistically significant, showing a reduction from baseline (p < 0.001) in total surface area, length and width of striae alba after three treatments at four-week intervals. Patient satisfaction scores of "Satisfied" and "Very Satisfied" for changes on texture, size, and overall improvement were 96.67%, 93.94% and 96.97% respectively.
The physicians' satisfaction showed concordant results that about 69.7% of all subjects had >50% improvement. Mean pain score was low at 2.33 (0 is no pain and 10 is intolerable pain). Post-inflammatory hyperpigmentation (PIH) was observed in 6 patients (18.1%), which improved with topical 4% hydroquinone.
As 90 percent of women experience stretch marks, this represents significant new potential for Venus Viva™ and your practice. This may well be an opportunity to establish your office as a leader in this exciting treatment. Download the report by clicking on the button below to learn more!